Loading clinical trials...

RECRUITINGPhase 2NCT06940427

Development of FAPI PET as a Non-invasive Biomarker of Pulmonary Fibrogenesis

The goal of this clinical trial is to gain more information about how fibroblast activation protein inhibitor (FAPI) binds to a certain type of cells in fibrotic lung tissue and how this information c...

Lead sponsor: University of Wisconsin, Madison•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Radiology Studies

CONTACT

608-282-8349 Radstudy@uwhealth.org

Related studies

RECRUITING

Practice of Oxygenation and Respiratory Support During Fiberoptic Bronchoscopy

NCT05681962 · Acute Respiratory Failure, Pneumonia, and more

RECRUITING

Longitudinal Observational Study on the Course of Cystic Fibrosis Lung Disease in Patients Following Newborn Screening

NCT02270476 · Cystic Fibrosis Lung Disease

COMPLETEDNA

Automated Oxygen Titration During Walking in Patients With Lung Fibrosis (OXYWILD)

NCT06465654 · Fibrosis Lung, Respiratory Therapy

COMPLETEDPhase 2

Preventive Inhalation of Hypertonic Saline in Infants With Cystic Fibrosis

NCT01619657 · Cystic Fibrosis Lung Disease

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 11, 2026Terms

Trial snapshot

StatusRECRUITING

PhasePHASE2

Enrollment50

Start dateNov 2025

Last updatedMar 11, 2026

Condition

Fibrosis Lung

Locations shown

University of Wisconsin - Madison

Madison, Wisconsin

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 11, 2026Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions